Empower Clinics Inc EPWCF

Healthcare Medical Care

Empower Clinics Inc. is a Canada-based integrated healthcare and medical device company with multi-disciplinary clinics. The Company provides body and mind wellness for patients through its medical clinics, digital and telemedicine care, medical diagnostics laboratories, and sale of medical devices. Its segments include Health & Wellness, comprising clinic operations, patient visits, and telemedicine services; Diagnostics & Technology, comprising the diagnostic testing services provided by Kai Medical, and the sale of medical equipment by Kai Medical Canada Corp. and MediSure; and Corporate. It is focused on offering clinical trial services, such as clinical trial design, patient recruitment, data management and regulatory compliance for the pharmaceutical, biotechnology and medical device industries. It has two clinical research sites in Dallas, Texas, becoming a site management organization (SMO) with six principal investigators (PI) with multiple clinical trials under application.

GREY:EPWCF - Post by User

Empower Clinics Inc > 2021 revenue

<< Previous

Bullboard Posts

Next >>

Comment by Smokey1958on Jan 23, 2021 9:57am

329 Views

Post# 32367640

RE:2021 revenue

You might be way off, Tankumo, but that's a relative thing. The key to their Q3 NR was that they had experienced a 67% increase in revenue for 9 months ending September 30, 2020 (in US dollars). Their annual revenue as posted by Webbroker is $3 million (presumably that's year end 2019). A great deal has happened since then.

If their annual revenue for 2020 in USD is somewhere between $5 million to 10 million, increasing that by even 5x would be quite a feat, but certainly not impossible. They would not be doubling the size of Kai Medical on a whim, they will have definitely carried out a business forecast to determine the viability of doing so. Their other acquisitions this year have not yet significantly influenced an annual Financials Report.

All evidence points to an amazing breakout 2021 for CBDT. They are streamlining the businesses they have acquired, continuing to expand and diversify their portfolio of businesses and have a proven leader in Steve. All looks great for those willing to be patiently long. If you're here to make a quick buck I don't think any one NR is going to send this flying (and that's a great thing). I honestly believe this is one stock that shorters will find challenging to significantly manipulate because growth will be gradual and sustainable.

Have a great weekend and GLTA!

tankumo wrote: I crunched some numbers and I feel that it is possible to see $100 million revenue for this year, covid test plus telemedicine revenues combined.

Am I way off, anyone?